Your browser doesn't support javascript.
loading
Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A.
Alexander, M S; Gasperini, M J; Tsai, P T; Gibbs, D E; Spinazzola, J M; Marshall, J L; Feyder, M J; Pletcher, M T; Chekler, E L P; Morris, C A; Sahin, M; Harms, J F; Schmidt, C J; Kleiman, R J; Kunkel, L M.
Afiliación
  • Alexander MS; Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
  • Gasperini MJ; Departments of Pediatrics and Genetics, Harvard Medical School, Boston, MA, USA.
  • Tsai PT; The Stem Cell Program, Boston Children's Hospital, Boston, MA, USA.
  • Gibbs DE; Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
  • Spinazzola JM; The F.M. Kirby Neurobiology Center, Translational Neuroscience Center, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Marshall JL; Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
  • Feyder MJ; Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
  • Pletcher MT; Departments of Pediatrics and Genetics, Harvard Medical School, Boston, MA, USA.
  • Chekler EL; Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
  • Morris CA; Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
  • Sahin M; Rare Disease Research Unit, Pfizer, Cambridge, MA, USA.
  • Harms JF; Rare Disease Research Unit, Pfizer, Cambridge, MA, USA.
  • Schmidt CJ; Rare Disease Research Unit, Pfizer, Cambridge, MA, USA.
  • Kleiman RJ; The F.M. Kirby Neurobiology Center, Translational Neuroscience Center, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Kunkel LM; Neuroscience Research Unit, Pfizer Global Research and Development, Cambridge, MA, USA.
Transl Psychiatry ; 6(9): e901, 2016 Sep 27.
Article en En | MEDLINE | ID: mdl-27676442
ABSTRACT
Duchenne muscular dystrophy is caused by mutations in the DYSTROPHIN gene. Although primarily associated with muscle wasting, a significant portion of patients (approximately 25%) are also diagnosed with autism spectrum disorder. We describe social behavioral deficits in dystrophin-deficient mice and present evidence of cerebellar deficits in cGMP production. We demonstrate therapeutic potential for selective inhibitors of the cGMP-specific PDE5A and PDE9A enzymes to restore social behaviors in dystrophin-deficient mice.

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Transl Psychiatry Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Transl Psychiatry Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos